Tasted masked veterinary solid compositions
Abstract
The present invention relates to the supply and production of an animal medicine consisting of a substrate in pellet or tablet form, which is attractive to livestock and domestic animals, in which fine-grained particles of a neutral-tasting, physiologically compatible, solid carrier material are embedded, which is characterised in that said fine-grained particles of carrier material have an average diameter of 0.09 to 0.8 mm and are coated with an active substance from veterinary medicine, and said active substance layer is covered with a protective layer of a physiologically compatible polymer matrix, and to the production of this animal medicine. It also relates to the usage of said double-coated, fine-grained particles of carrier material in the production of a preparation for veterinary medicine.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . An animal medicine in pellet or tablet form comprising:
a substrate, whereby said substrate consists of animal feed; and coated particles whereby said substrate and said coated particles are intimately mixed and whereby said coated particles comprise
a carrier material having an average diameter of approximately 0.8 mm or less;
an active ingredient casing comprising at least one veterinary active ingredient whereby said active ingredient casing coats said carrier material; and
a masking protective layer whereby said masking protective layer coats said active ingredient casing.
22 . The animal medicine of claim 21 whereby said carrier material has an average diameter of approximately 0.09 mm and 0.8 mm.
23 . The animal medicine of claim 21 whereby said carrier material is selected from the group consisting of cellulose, starch, saccharose, lactose, and sugar.
24 . The animal medicine of claim 21 whereby said masking protective layer is selected from the group consisting of shellac, a cellulose polymer, an acrylic acid polymer, a methacrylic acid polymer, a maleic acid anhydride polymer, a polyvinyl pyrrolidone polymer, a polyvinyl alcohol polymer, or a combination of said polymers.
25 . The animal medicine of claim 21 further comprising one or more additives whereby said additives are selected from the group consisting of proteins, vitamins, minerals, artificial aromatics, and natural aromatics.
26 . The animal medicine of claim 21 whereby said substrate consists of lysed yeast.
27 . The animal medicine of claim 21 whereby said veterinary active ingredient is selected from the group consisting of anti-parasitic, anti-bacterial, anti-viral, and neurotropic.
28 . The animal medicine of claim 27 whereby said veterinary active ingredient is benazepril.
29 . A method of making an animal medicine comprising
coating a carrier material with at least one veterinary active ingredient whereby said carrier material has an average diameter of approximately 0.8 mm or less; coating said at least one veterinary active ingredient with a masking protective layer to form coated particles; intimately mixing said coated particles with a substrate whereby said substrate consists of animal feed; and compressing said intimately mixed coated particles and substrate into tablets or pellets of appropriate size.
30 . The method of claim 29 whereby said carrier material has an average diameter of approximately 0.09 mm to approximately 0.8 mm.
31 . The method of claim 29 whereby said carrier material consists of cellulose, starch, saccharose, lactose or sugar.
32 . The method of claim 29 whereby said masking protective layer is selected from the group consisting of shellac, a cellulose polymer, an acrylic acid polymer, a methacrylic acid polymer, a maleic acid anhydride polymer, a polyvinyl pyrrolidone polymer, a polyvinyl alcohol polymer, or a combination of said polymers.
33 . The method of claim 29 further comprising adding one or more additive to said intimately mixed coated particles and substrate whereby said additive is selected from the group consisting of proteins, vitamins, minerals, artificial aromatic substances, and natural aromatic substances.
34 . The method of claim 29 whereby said substrate consists of lysed yeast.
35 . The method of claim 29 whereby said veterinary active ingredient is selected from the group consisting of anti-parasitic, anti-bacterial, anti-viral, and neurotropic.
36 . The method of claim 35 whereby said veterinary active ingredient is benazepril.Join the waitlist — get patent alerts
Track US2005169971A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.